文献速递外周动脉疾病

利伐沙班联合阿司匹林治疗外周动脉疾病患者中外周干预的影响:XATOA登记研究分析

Effect of Peripheral Interventions in Patients with Peripheral Artery Disease Receiving Rivaroxaban and Aspirin: Analyses from the XATOA Registry.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2024-07-14

XATOA为国际多中心前瞻性单臂登记研究,纳入5532例接受利伐沙班2.5mg每日两次联合阿司匹林双通路抑制的患者,其中2820例(51.0%)为下肢外周动脉疾病,1736例(61.6%)有既往下肢血运重建史、1084例(38.4%)无既往血运重建史。有既往血运重建史者任何治疗紧急临床事件发生率高于无既往血运重建史者(15.0% vs 9.4%),肢体事件发生率差异更大,包括主要不良肢体事件(9.06 vs 4.09事件/100患者年)。心肌梗死、卒中和主要出血发生率两组相似。既往血运重建可预测肢体事件。

要点

  • 有既往下肢血运重建史者任何治疗紧急临床事件发生率15.0%,无既往血运重建史者9.4%。
  • 主要不良肢体事件发生率有既往血运重建史者9.06事件/100患者年,无既往血运重建史者4.09事件/100患者年。
  • 心肌梗死、卒中和主要出血发生率在两个亚组中相似。

核心结论

  • XATOA亚分析发现既往下肢血运重建与肢体事件发生率增加相关,与COMPASS和VOYAGER PAD结果一致。
  • 无论有无下肢血运重建史,出血发生率均低,与上述试验结果一致。

研究设计与样本

  • XATOA为国际多中心前瞻性单臂登记研究。
  • 本亚分析按下肢血运重建史评估下肢外周动脉疾病患者,患者接受利伐沙班2.5mg每日两次联合阿司匹林双通路抑制,随访12个月或以上。
  • XATOA共纳入5532例患者,其中2820例(51.0%)为下肢外周动脉疾病,1736例(61.6%)有既往下肢血运重建史,1084例(38.4%)无既往下肢血运重建史。

主要发现

  • 有既往下肢血运重建史者任何治疗紧急临床事件发生率为15.0%,无既往下肢血运重建史者为9.4%。
  • 主要不良肢体事件发生率有既往下肢血运重建史者为9.06事件/100患者年,无既往下肢血运重建史者为4.09事件/100患者年。
  • 两个亚组心肌梗死、卒中和主要出血发生率相似。
  • 在开始双通路抑制前6个月或以内接受下肢血运重建的患者,临床事件发生率一般高于6个月以上者,与血运重建类型无关。
  • 多变量分析显示既往下肢血运重建可预测肢体事件。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the characteristics and clinical outcomes of patients with lower extremity peripheral artery disease (PAD) in XATOA receiving dual pathway inhibition (DPI) with rivaroxaban 2.5 mg twice daily plus aspirin according to lower extremity revascularisation (LER) history. METHODS: XATOA is an international, multicentre, prospective, single arm registry study. This subanalysis investigated patients with lower extremity PAD according to LER history. Patients with coronary artery disease, PAD, or both, receiving DPI were followed for 12 or more months. Baseline characteristics and clinical outcomes were assessed according to LER history. A time dependency analysis assessed outcomes by time between the most recent LER procedure and the start of DPI. A multivariable analysis assessed the influence of patient characteristics on clinical outcomes. RESULTS: In XATOA (n = 5 532), 2 820 (51.0%) patients had lower extremity PAD, of whom 1 736 (61.6%) had prior LER and 1 084 (38.4%) had no prior LER. Baseline characteristics were generally similar between patients with or without prior LER. A higher proportion of patients with prior LER experienced any treatment emergency clinical events compared with those without prior LER (15.0% vs. 9.4%, respectively), with greater differences observed between incidence rates of limb events, including major adverse limb events (9.06 vs. 4.09 events per 100 patient years, respectively). Similar rates of myocardial infarction, stroke, and major bleeding were observed in both subgroups. Clinical event rates were generally higher in patients who had previous LER for six months or less compared with patients who had previous LET for more than six months before starting DPI, regardless of LER type. Multivariable analyses showed that prior LER was predictive of limb events. CONCLUSION: This subanalysis of XATOA found that prior LER was associated with increased rates of limb events, consistent with results of COMPASS and VOYAGER PAD. Rates of bleeding were also low regardless of LER history and consistent with the findings from these trials.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Debus ES, Aboyans V, Bosch J, et al. Effect of Peripheral Interventions in Patients with Peripheral Artery Disease Receiving Rivaroxaban and Aspirin: Analyses from the XATOA Registry. Eur J Vasc Endovasc Surg. 2024. PMID: 39009110. doi:10.1016/j.ejvs.2024.07.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。